Publications by authors named "Teba Alnima"

Claim this Profile
B
Branched endovascular aneurysm repair complicated by disseminated intravascular coagulation while using tocilizumab.
Ella Lubberdink, Saskia E M Schols, Teba Alnima, Mark Dirven

J Vasc Surg Cases Innov Tech· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?
Teba Alnima, Mark M Smits, Nordin M J Hanssen

Curr Opin Lipidol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort.
Tom W van de Berg, Mark M G Mulder, Teba Alnima, Magdolna Nagy, Rene van Oerle

Front Cardiovasc Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Coagulopathy: From Pathogenesis to Treatment.
Teba Alnima, Mark M G Mulder, Bas C T van Bussel, Hugo Ten Cate

Acta Haematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High flow nasal cannula in older vulnerable COVID-19 patients: A missed opportunity?
Ruth A L Willems, Bart Spaetgens, Lennart H Conemans, Geertjan Wesseling, Coen D A Stehouwer, Teba Alnima

Respir Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A known unknown? Pharmacological prevention of venous thromboembolism in nursing home residents.
Renée A G Brüggemann, Teba Alnima, Steffie H A Brouns, Nordin M J Hanssen, Jos M G A Schols

J Am Geriatr Soc· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baropacing as a new option for treatment of resistant hypertension.
Teba Alnima, Peter W de Leeuw, Abraham A Kroon

Eur J Pharmacol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.
Teba Alnima, Emilie J B M Goedhart, Randy Seelen, Chris P M van der Grinten, Peter W de Leeuw

Hypertension· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral or unilateral stimulation for baroreflex activation therapy.
Peter W de Leeuw, Teba Alnima, Eric Lovett, Domenic Sica, John Bisognano

Hypertension· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baroreflex activation therapy for patients with drug-resistant hypertension.
Teba Alnima, Abraham A Kroon, Peter W de Leeuw

Expert Rev Cardiovasc Ther· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension.
Teba Alnima, Peter W de Leeuw, Frans E S Tan, Abraham A Kroon,

Hypertension· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension.
Teba Alnima, Ingrid Scheffers, Peter W De Leeuw, Bjorn Winkens, Heidi Jongen-Vancraybex

J Hypertens· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baroreflex activation therapy for the treatment of drug-resistant hypertension: new developments.
Teba Alnima, Peter W de Leeuw, Abraham A Kroon

Cardiol Res Pract· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis